mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
8e-07 |
mRNA |
Axitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
1e-05 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
2e-05 |
mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
3e-05 |
mRNA |
AZD-2281 |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
4e-05 |
mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
4e-05 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
7e-05 |
mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
8e-05 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0001 |
mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0001 |